Isolation and functional analysis of circulating dendritic cells from hepatitis C virus (HCV) RNA-positive and HCV RNA-negative patients with chronic hepatitis C: role of antiviral therapy
Authors:
Open Access
- 30 June 2004
- journal article
- Published by Oxford University Press (OUP) in Clinical and Experimental Immunology
- Vol. 137 (2) , 417-423
Abstract
Hepatitis C virus (HCV) RNA has been localized in antigen‐presenting dendritic cells (DCs) from patients with chronic hepatitis C (CHC). DCs from patients with CHC also exhibit impaired functional capacities. However, HCV RNA in DCs and functional impairment of DCs in CHC might be independent or interrelated events. Moreover, the impact of antiviral therapy on the functions of DCs in CHC is not well documented. In order to address these issues, we took advantage of antiviral therapy in these patients. Ten patients with CHC, expressing HCV RNA in circulating DCs, became negative for HCV RNA in circulating DCs after therapy with interferon‐α and ribavirin for 4 weeks. The functions of DCs from HCV RNA+ patients (isolated before antiviral therapy) and HCV RNA– patients (isolated 4 weeks after antiviral therapy) were compared in allogenic mixed leucocyte reactions. In comparison to circulating DCs from normal control subjects, DCs from HCV RNA+ patients had a significantly decreased capacity to stimulate allogenic T lymphocytes (P < 0·01) and produce interleukin‐12 (P < 0·05). However, the allostimulatory capacity of circulating DCs from HCV RNA– patients was several‐fold higher compared to that of HCV RNA+ DCs from the same patient. DC from HCV RNA– patients also produced significantly higher levels of interleukin‐12 compared to HCV RNA+ DCs from the same patient (P < 0·01). Taken together, this study is the first to provide experimental evidence regarding the impact of HCV RNA and antiviral therapy on the function of DCs in patients with CHC.Keywords
This publication has 24 references indexed in Scilit:
- Infection and dysfunction of circulating blood dendritic cells and their subsets in chronic hepatitis C virus infectionJournal of Gastroenterology, 2004
- IFN-α promotes the rapid differentiation of monocytes from patients with chronic myeloid leukemia into activated dendritic cells tuned to undergo full maturation after LPS treatmentBlood, 2004
- Evidence of Viral Replication in Circulating Dendritic Cells during Hepatitis C Virus InfectionThe Journal of Infectious Diseases, 2003
- Hepatitis C Virus Core and Nonstructural Protein 3 Proteins Induce Pro- and Anti-inflammatory Cytokines and Inhibit Dendritic Cell DifferentiationThe Journal of Immunology, 2003
- Impaired function of antigen-presenting dendritic cells in patients with chronic hepatitis B: localization of HBV DNA and HBV RNA in blood DC by in situ hybridization.International Journal of Molecular Medicine, 2003
- Macrophage migration inhibitory factor activates antigen-presenting dendritic cells and induces inflammatory cytokines in ulcerative colitisClinical and Experimental Immunology, 2002
- Activation and maturation of antigen-presenting dendritic cells during vaccine therapy in patients with chronic hepatitis due to hepatitis B virusHepatology Research, 2002
- Regulation of T Cell Immunity by Dendritic CellsCell, 2001
- Prognostic importance of antigen‐presenting dendritic cells during vaccine therapy in a murine hepatitis B virus carrierImmunology, 1999
- Typing hepatitis C virus by polymerase chain reaction with type-specific primers: application to clinical surveys and tracing infectious sourcesJournal of General Virology, 1992